FDA Drug Application (205692) for BASAGLAR by ELI LILLY AND CO

Back to FDA Applications sponsored by ELI LILLY AND CO

Application Number205692
Product Number001
FormSOLUTION;SUBCUTANEOUS
Dosage300 UNITS/3ML (100 UNITS/ML)
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameBASAGLAR
Active IngredientINSULIN GLARGINE



Back to FDA Applications sponsored by ELI LILLY AND CO